Alzheimer’s Disease/Dementia News

Greater residential levels of fine particulate matter air pollution, especially from agriculture and wildfires, were linked to higher rates of dementia, according to study results published in JAMA Internal Medicine.

C2N Diagnostics released the PrecivityAD2 blood test, which uses positron emission tomography scans and cerebrospinal fluid tests to assist in accurate diagnosis for those presenting with signs or symptoms of Alzheimer’s disease.

Treatment with an investigational anti-amyloid therapeutic for adults with mild Alzheimer’s disease was safe, efficacious and demonstrated a significant immune response up to 78 weeks, per a study published in EBioMedicine.

A neuroscience company and an emerging artificial intelligence technology firm have announced a partnership that aims to boost access to routine brain care and to facilitate early detection of Alzheimer’s disease and related dementias.

Adults older than 60 years have significantly worse cognition and higher depression after experiencing moderate to severe trauma, according to research presented at the Alzheimer’s Association International Conference.

Early menopause and vascular processes may synergistically contribute to increased risk for Alzheimer’s disease in women, according to a poster presentation at the Alzheimer’s Association International Conference.

New guidance from the American Academy of Neurology on early Alzheimer’s disease treatment calls for greater collaboration from patients, caregivers and clinicians as well as the embrace of new therapeutics.

The risk for dementia was 2.41 times greater in Danish adults with diagnosed depression, an association that persisted when depression was diagnosed in early and middle life, according to research in JAMA Neurology.

Prevalence of mild cognitive impairment among United States military veterans aged 65 years and older increased from 2010 to 2019, according to a poster presented at the Alzheimer’s Association International Conference.

New county-level estimates of Alzheimer’s prevalence released at the Alzheimer’s Association International Conference may help inform allocations of funding, staffing and other resources toward caring for patients.